Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the epstein-barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Gross, Henrik ^a   Hennard, Christine ^b   Masouris, Ilias ^b   Cassel, Christian ^a   Barth, Stephanie ^a   Stober Grässer, Ute ^a   Mamiani, Alfredo ^a   Moritz, Bodo ^c   Ostareck, Dirk ^d   Ostareck Lederer, Antje ^d   Neuenkirchen, Nils ^e   Fischer, Utz ^e   Deng, Wen ^f   Leonhardt, Heinrich ^f   Noessner, Elfriede ^b   Kremmer, Elisabeth ^b   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; EPSTEIN BARR VIRUS ANTIGEN 2; GLYCINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; LATENT MEMBRANE PROTEIN 2;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; EMBRYO; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARGININE; CELL LINE; DNA; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; IMMUNOPRECIPITATION; METHYLATION; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; MUTANT PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN TRANSPORT; REPETITIVE SEQUENCES, AMINO ACID; SNRNP CORE PROTEINS; TRANSFECTION; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

HUMAN ENDOGENOUS RETROVIRUS K; HUMAN HERPESVIRUS 4;

EID: 84864560763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042106     Document Type: Article

References (82)

1. Crawford DH, (2001) Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 461-473.
2. Kieff E, Rickinson AE, (2007) Epstein-Barr Virus and its replication. In: Knipe D, Griffin DE, Lamb RA, Strauss SE, Howley PM, et al., editors. editors. Fields Virology. 5 ed. Philadelphia: Lippincott-Raven. pp. 2603-2654.
3. Bornkamm GW, Hammerschmidt W, (2001) Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 437-459.
4. Zimber Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, et al. (1993) The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J 12: 167-175.
5. Ling PD, Hayward SD, (1995) Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J Virol 69: 1944-1950.
6. Henkel T, Ling PD, Hayward SD, Peterson MG, (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265: 92-95.
7. Zimber Strobl U, Strobl LJ, (2001) EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol 11: 423-434.
8. Cohen JI, Wang F, Kieff E, (1991) Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol 65: 2545-2554.
9. Grundhoff AT, Kremmer E, Tureci O, Glieden A, Gindorf C, et al. (1999) Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C. J Biol Chem 274: 19136-19144.
10. Barth S, Liss M, Voss MD, Dobner T, Fischer U, et al. (2003) Epstein-Barr virus nuclear antigen 2 binds via its methylated Arginine- glycine repeat to the survival motor neuron protein. J Virol 77: 5008-5013.
11. Voss MD, Hille A, Barth S, Spurk A, Hennrich F, et al. (2001) Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter. J Virol 75: 11781-11790.
12. Tsui S, Schubach WH, (1994) Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. J Virol 68: 4287-4294.
13. Wu DY, Krumm A, Schubach WH, (2000) Promotor-specific targeting of human SWi-SNF complex by Epstein-Barr virus nuclear protein 2. J Virol 74: 8893-8903.
14. Grässer FA, Haiss P, Göttel S, Mueller Lantzsch N, (1991) Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. J Virol 65: 3779-3788.
15. Gross H, Barth S, Palermo RD, Mamiani A, Hennard C, et al. (2010) Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting. Virology 397: 299-310.
16. Tong X, Yalamanchili R, Harada S, Kieff E, (1994) The EBNA-2 Arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. J Virol 68: 6188-6197.
17. Rickinson AB, Young LS, Rowe M, (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61: 1310-1317.
18. Cancian L, Bosshard R, Lucchesi W, Karstegl CE, Farrell PJ, (2011) C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7. PLoS Pathog 7: e1002164.
19. Gary JD, Clarke S, (1998) RNA and protein interactions modulated by protein Arginine methylation. Prog Nucleic Acid Res Mol Biol 61: 65-131.
20. Paik WK, Kim S, (1967) Enzymatic methylation of protein fractions from calf thymus nuclei. Biochem Biophys Res Commun 29: 14-20.
21. Bedford MT, Richard S, (2005) Arginine methylation an emerging regulator of protein function. Mol Cell 18: 263-272.
22. Cook JR, Lee JH, Yang ZH, Krause CD, Herth N, et al. (2006) FBXO11/PRMT9, a new protein Arginine methyltransferase, symmetrically dimethylates Arginine residues. Biochem Biophys Res Commun 342: 472-481.
23. Lee J, Sayegh J, Daniel J, Clarke S, Bedford MT, (2005) PRMT8, a new membrane-bound tissue-specific member of the protein Arginine methyltransferase family. J Biol Chem 280: 32890-32896.
24. Swanson MS, Dreyfuss G, (1988) Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol Cell Biol 8: 2237-2241.
25. Bomsztyk K, Denisenko O, Ostrowski J, (2004) hnRNP K: one protein multiple processes. Bioessays 26: 629-638.
26. Ostareck-Lederer A, Ostareck DH, (2004) Control of mRNA translation and stability in haematopoietic cells: the function of hnRNPs K and E1/E2. Biol Cell 96: 407-411.
27. Uribe DJ, Guo K, Shin YJ, Sun D, (2011) Heterogeneous nuclear ribonucleoprotein K and nucleolin as transcriptional activators of the vascular endothelial growth factor promoter through interaction with secondary DNA structures. Biochemistry 50: 3796-3806.
28. Ostareck-Lederer A, Ostareck DH, Hentze MW, (1998) Cytoplasmic regulatory functions of the KH-domain proteins hnRNPs K and E1/E2. Trends Biochem Sci 23: 409-411.
29. Ostareck-Lederer A, Ostareck DH, Rucknagel KP, Schierhorn A, Moritz B, et al. (2006) Asymmetric Arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-Arginine methyltransferase 1 inhibits its interaction with c-Src. J Biol Chem 281: 11115-11125.
30. Naarmann IS, Harnisch C, Flach N, Kremmer E, Kuhn H, et al. (2008) mRNA silencing in human erythroid cell maturation: heterogeneous nuclear ribonucleoprotein K controls the expression of its regulator c-Src. J Biol Chem 283: 18461-18472.
31. Naarmann IS, Harnisch C, Muller-Newen G, Urlaub H, Ostareck-Lederer A, et al. (2010) DDX6 recruits translational silenced human reticulocyte 15-lipoxygenase mRNA to RNP granules. Rna 16: 2189-2204.
32. Gross H, Barth S, Pfuhl T, Willnecker V, Spurk A, et al. (2011) The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2). Int J Cancer 129: 1105-1115.
33. Meister G, Eggert C, Buhler D, Brahms H, Kambach C, et al. (2001) Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr Biol 11: 1990-1994.
34. Friesen WJ, Massenet S, Paushkin S, Wyce A, Dreyfuss G, (2001) SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylArginine-containing protein targets. Mol Cell 7: 1111-1117.
35. Friesen WJ, Dreyfuss G, (2000) Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). J Biol Chem 275: 26370-26375.
36. Hennard C, Pfuhl T, Buettner M, Becker KF, Knofel T, et al. (2006) The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV association of human cancers. J Pathol 209: 430-435.
37. Meister G, Buhler D, Pillai R, Lottspeich F, Fischer U, (2001) A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs. Nat Cell Biol 3: 945-949.
38. Liu Q, Fischer U, Wang F, Dreyfuss G, (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90: 1013-1021.
39. Kremmer E, Kranz B, Hille A, Klein K, Eulitz M, et al. (1995) Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). Virology 208: 336-342.
40. Chan JY, Hsieh TY, Liu ST, Chou WY, Chung MH, et al. (2009) Physical and functional interactions between hnRNP K and PRMT family proteins. FEBS Lett 583: 281-286.
41. Li H, Liu J, (2010) Identification of heterogeneous nuclear ribonucleoprotein K as a transactivator for human low density lipoprotein receptor gene transcription. J Biol Chem 285: 17789-17797.
42. Ritchie SA, Pasha MK, Batten DJ, Sharma RK, Olson DJ, et al. (2003) Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription. Nucleic Acids Res 31: 1502-1513.
43. Takimoto M, Tomonaga T, Matunis M, Avigan M, Krutzsch H, et al. (1993) Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. J Biol Chem 268: 18249-18258.
44. Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, et al. (1996) Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol 16: 2656-2669.
45. Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, et al. (1998) Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem. 273: 17651-17659.
46. Lau JS, Baumeister P, Kim E, Roy B, Hsieh TY, et al. (2000) Heterogeneous nuclear ribonucleoproteins as regulators of gene expression through interactions with the human thymidine kinase promoter. J Cell Biochem 79: 395-406.
47. Zimber Strobl U, Strobl LJ, Meitinger C, Hinrichs R, Sakai T, et al. (1994) Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J 13: 4973-4982.
48. Sauder C, Götzinger N, Schubach WH, Horvath GC, Kremmer E, et al. (1996) Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies. J Gen Virol 77: 991-996.
49. Zimber-Strobl U, Strobl LJ, (2001) EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol 11: 423-434.
50. Lee JH, Cook JR, Yang ZH, Mirochnitchenko O, Gunderson S, et al. (2004) PRMT7: A new protein Arginine methyltransferase that synthesizes symmetric dimethylArginine. J Biol Chem 19: 19.
51. Brahms H, Raymackers J, Union A, de Keyser F, Meheus L, et al. (2000) The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylArginines, which form a major B-cell epitope for anti-Sm autoantibodies. J Biol Chem 275: 17122-17129.
52. Jurica MS, Moore MJ, (2003) Pre-mRNA splicing: awash in a sea of proteins. Mol Cell 12: 5-14.
53. Zou T, Yang X, Pan D, Huang J, Sahin M, et al. (2011) SMN deficiency reduces cellular ability to form stress granules, sensitizing cells to stress. Cell Mol Neurobiol 31: 541-550.
54. Hua Y, Zhou J, (2004) Survival motor neuron protein facilitates assembly of stress granules. FEBS Lett 572: 69-74.
55. Rosales R, Sutter G, Moss B, (1994) A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. Proc Natl Acad Sci U S A 91: 3794-3798.
56. Smith WA, Schurter BT, Wong-Staal F, David M, (2004) Arginine methylation of RNA helicase a determines its subcellular localization. J Biol Chem 279: 22795-22798.
57. Forsman A, Ruetschi U, Ekholm J, Rymo L, (2008) Identification of intracellular proteins associated with the EBV-encoded nuclear antigen 5 using an efficient TAP procedure and FT-ICR mass spectrometry. J Proteome Res 7: 2309-2319.
58. Mikula M, Bomsztyk K, (2011) Direct recruitment of ERK cascade components to inducible genes is regulated by heterogeneous nuclear ribonucleoprotein (hnRNP) K. J Biol Chem. 286: 9763-9775.
59. Wei CC, Zhang SL, Chen YW, Guo DF, Ingelfinger JR, et al. (2006) Heterogeneous nuclear ribonucleoprotein K modulates angiotensinogen gene expression in kidney cells. J Biol Chem 281: 25344-25355.
60. Adolph D, Flach N, Mueller K, Ostareck DH, Ostareck-Lederer A, (2007) Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site. Mol Cell Biol 27: 1758-1770.
61. Marchand V, Santerre M, Aigueperse C, Fouillen L, Saliou JM, et al. (2011) Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K. RNA Biol. 8: 325-342.
62. Mikula M, Dzwonek A, Karczmarski J, Rubel T, Dadlez M, et al. (2006) Landscape of the hnRNP K protein-protein interactome. Proteomics 6: 2395-2406.
63. Garcia-Jurado G, Llanes D, Moreno A, Soria B, Tejedo JR, (2011) Monoclonal antibody that recognizes a domain on heterogeneous nuclear ribonucleoprotein K and PTB-associated splicing factor. Hybridoma (Larchmt) 30: 53-59.
64. Fuentes Panana EM, Peng R, Brewer G, Tan J, Ling PD, (2000) Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J Virol 74: 8166-8175.
65. Melcak I, Cermanova S, Jirsova K, Koberna K, Malinsky J, et al. (2000) Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs. Mol Biol Cell 11: 497-510.
66. Steinmetz EJ, (1997) Pre-mRNA processing and the CTD of RNA polymerase II: the tail that wags the dog? Cell 89: 491-494.
67. Neugebauer KM, Roth MB, (1997) Distribution of pre-mRNA splicing factors at sites of RNA polymerase II transcription. Genes Dev 11: 1148-1159.
68. Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, et al. (1999) The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J Virol 73: 4481-4484.
69. Alfieri C, Birkenbach M, Kieff E, (1991) Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181: 595-608.
70. Lee MH, Mori S, Raychaudhuri P, (1996) trans-Activation by the hnRNP K protein involves an increase in RNA synthesis from the reporter genes. J Biol Chem 271: 3420-3427.
71. Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, et al. (1977) Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19: 27-33.
72. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, et al. (2008) Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36: 666-675.
73. Zhang X, Cheng X, (2003) Structure of the predominant protein Arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 11: 509-520.
74. Ostareck DH, Ostareck-Lederer A, Shatsky IN, Hentze MW, (2001) Lipoxygenase mRNA silencing in erythroid differentiation: The 3′UTR regulatory complex controls 60S ribosomal subunit joining. Cell 104: 281-290.
75. Szczyrba J, Nolte E, Wach S, Kremmer E, Stohr R, et al. (2011) Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma. Mol Cancer Res 9: 791-800.
76. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W, (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245-8250.
77. Zolghadr K, Mortusewicz O, Rothbauer U, Kleinhans R, Goehler H, et al. (2008) A fluorescent two-hybrid assay for direct visualization of protein interactions in living cells. Mol Cell Proteomics 7: 2279-2287.
78. Tsukamoto T, Hashiguchi N, Janicki SM, Tumbar T, Belmont AS, et al. (2000) Visualization of gene activity in living cells. Nat Cell Biol 2: 871-878.
79. Dambacher S, Deng W, Hahn M, Sadic D, Frohlich J, et al. (2012) CENP-C facilitates the recruitment of M18BP1 to centromeric chromatin. Nucleus 3.
80. Dignam JD, Lebovitz RM, Roeder RG, (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489.
81. Sauder C, Haiss P, Grässer FA, Zimber Strobl U, Mueller Lantzsch N, (1994) DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines. J Gen Virol 75: 3067-3079.
82. Maier S, Santak M, Mantik A, Grabusic K, Kremmer E, et al. (2005) A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent. J Virol 79: 8784-8792.